Internal Medicine Doctors in Herndon, VA Accepting Medicare

8 Internal Medicine doctors found. Showing 1 - 8

Wesam Hassen Moustafa Hussein, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13326 Horsepen Woods Lane, Herndon, VA 20171 Phone: 609-335-6595

Glen Edgar Tomkins, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1141 Elden St, Suite 300, Herndon, VA 20170 Phone: 703-481-8160

Dr. Ravi R Iyer, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13505 Dulles Technology Drive, Suite 1a, Herndon, VA 20171 Phone: 703-404-5900    Fax: 703-421-1099

Dr. Shalini Goyal Kaneriya, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2579 John Milton Dr Ste 300, Herndon, VA 20171 Phone: 703-828-0799    Fax: 571-525-2963

Phetpailin Amaralikit, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 420 Elden St, Herndon, VA 20170 Phone: 571-353-1899    Fax: 888-974-1477

Dr. Han Tonthat, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 Sterling Rd Ste 104, Herndon, VA 20170 Phone: 703-840-0610    Fax: 571-323-3243

Musaab Esmael, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13000 Elm Tree Dr, Herndon, VA 20171 Phone: 202-830-7577

Dr. Eskender Beyene, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1037 Sterling Rd, Suite # 102, Herndon, VA 20170 Phone: 202-270-6644    Fax: 703-657-2902

News Archive

AbbVie reports results from venetoclax Phase 2 clinical trial in AML at ASH 2014

AbbVie presented during an oral presentation at the American Society of Hematology's 56th Annual Meeting new results from a Phase 2 study of investigational compound venetoclax (ABT-199/GDC-0199) in patients with acute myelogenous leukemia (AML). AML is an aggressive and deadly type of blood cancer, in which the body produces too many of a specific type of white blood cell (myeloblast), which can crowd out healthy blood cells.

Extensive genomic, transcriptional diversity identified through massively parallel DNA and RNA sequencing

In a paper published in the online edition of Nature Genetics on July 3, 2011, sequencing specialists at Axeq Technologies, and scientists from Macrogen Inc., Genomic Medicine Institute at Seoul National University, Psoma Therapeutics Inc., Brigham and Women's Hospital and Harvard Medical School reported the discovery of a wide range of novel genetic variants based on the deep sequencing of 18 genomes and 17 transcriptomes of unrelated Korean individuals.

Alternatives to cigarette smoking may still pose a risk to human health due to over-use

Cigarette smoking kills approximately 440,000 Americans each year, according to the Centers for Disease Control and Protection. It's the leading cause of preventable death worldwide. In order to overcome this addiction, many people resort to nicotine replacement therapies.

Crescent Healthcare CIO selected as finalist for 'Chief Innovation Officer' Appy Award

Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent's business with the power of cloud computing.

Read more Medical News

› Verified 8 days ago